This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
#image_title By Dr. Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”
Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. People are microdosing psychedelics, vitamins, near everything for health purposes.
Mind Medicine, Inc. , a Canadian biotech firm, is entering Phase II clinicaltrials for two experimental treatments. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction. The other trial will test LSD microdosing as an ADHD treatment.
However, a company may be in possession of the most healing psychedelic compound in the world, but unless they can prove it through the clinicaltrial process, their superior medicine will mean little. Yes, of course, it matters greatly who has the most effective medical psychedelic molecule in specific circumstances.
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Andy Smith (D) stated that he is “working on a bill forming a psychedelic medicine task force so Minnesotans can access these life-affirming treatments.
“Their position as therapeutic practitioners, as well as their work in conducting the kind of clinicaltrials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”.
According to CAMH’s lead investigator, clinicaltrials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression. Optimi Health Corp.
It was personal, powerful, and it changed how thousands of us think about plant medicine. Finding the Right Dose (Every Person is Different) This is where medicine becomes part science, part art. Charlotte’s Legacy Lives On Charlotte Figi passed away in 2020, but her impact on medicine continues every single day.
Microdose report. What are the gaps in current psychedelic research, including questions about the methods of current clinicaltrials and other key scientific questions that need to be addressed to further our understanding of psychedelics? If not, would you initiate such a review? See the complete letter here: [link].
The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety.
We are pleased to share with you that earlier this fall, the Center for Psychedelic and Consciousness Research was founded at the Johns Hopkins School of Medicine. Scientific American recently outlined the legal implications surrounding psychedelic medicine. Dr. Johnson recently spoke about microdosing and its affects on creativity.
And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. What is microdosing? How do psychedelics work?
Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinicaltrial this past summer. Compass Pathways Releases Phase 2B Trial Results.
What’s new, however, is that the FDA is beginning to warm up to the idea of psychedelics having medicinal potential, despite being categorized as Schedule 1 substances with supposedly zero medicinal value. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.
Also of interest, The American Journal of Medicine adds: We found significant associations between marijuana use and smaller waist circumferences. As counterintuitive as it might sound, this conclusion is actually in line with a growing number of studies.
Although psychedelics have been used by humans for over 7,000 years across multiple different cultures, only in the past century have these medicines been outlawed by governments around the world. Fortunately, the past several years have seen a resurgence in awareness and interest in psychedelic medicine. in/timferriss/ [link].
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content